These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817 [TBL] [Abstract][Full Text] [Related]
23. Rapid detection of amoxicillin-susceptible Escherichia coli in fresh uncultured urine: a new tool to limit the use of broad-spectrum empirical therapy of community-acquired pyelonephritis. Chapelet G; Corvec S; Montassier E; Herbreteau G; Berrut G; Batard E; de Decker L Int J Antimicrob Agents; 2016 Jun; 47(6):486-9. PubMed ID: 27211827 [TBL] [Abstract][Full Text] [Related]
24. Changes in Antimicrobial Resistance of Urinary Tract Infections in Adult Patients over a 5-Year Period. Caskurlu H; Culpan M; Erol B; Turan T; Vahaboglu H; Caskurlu T Urol Int; 2020; 104(3-4):287-292. PubMed ID: 31940639 [TBL] [Abstract][Full Text] [Related]
25. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005). Rock W; Colodner R; Chazan B; Elias M; Raz R Isr Med Assoc J; 2007 Nov; 9(11):803-5. PubMed ID: 18085038 [TBL] [Abstract][Full Text] [Related]
26. Antimicrobial susceptibility of organisms causing community-acquired urinary tract infections in Gauteng Province, South Africa. Lewis DA; Gumede LY; van der Hoven LA; de Gita GN; de Kock EJ; de Lange T; Maseko V; Kekana V; Smuts FP; Perovic O S Afr Med J; 2013 Mar; 103(6):377-81. PubMed ID: 23725955 [TBL] [Abstract][Full Text] [Related]
27. Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients. Fatima S; Muhammad IN; Usman S; Jamil S; Khan MN; Khan SI Indian J Pharmacol; 2018; 50(2):69-74. PubMed ID: 30100654 [TBL] [Abstract][Full Text] [Related]
28. [Antimicrobial resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul]. Ozyurt M; Haznedaroğlu T; Sahiner F; Oncül O; Ceylan S; Ardiç N; Erdemoğlu A Mikrobiyol Bul; 2008 Apr; 42(2):231-43. PubMed ID: 18697421 [TBL] [Abstract][Full Text] [Related]
29. [The etiology of urinary tract infections and antimicrobial susceptibility: study based on children hospitalized in 2012]. Jackowska T; Chwiećko J; Hartmann P Dev Period Med; 2014; 18(4):470-6. PubMed ID: 25874786 [TBL] [Abstract][Full Text] [Related]
30. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464 [TBL] [Abstract][Full Text] [Related]
31. Antibiotic resistance of coliform bacteria from community-acquired urinary tract infections in the Zenica-Doboj Canton, Bosnia and Herzegovina. Uzunović-Kamberović S; Odobasić M; Husković A; Hutinović A; Ibranović N Med Glas (Zenica); 2010 Feb; 7(1):40-5. PubMed ID: 20387723 [TBL] [Abstract][Full Text] [Related]
32. Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections. Wang SS; Ratliff PD; Judd WR Int J Clin Pharm; 2018 Feb; 40(1):143-149. PubMed ID: 29147962 [TBL] [Abstract][Full Text] [Related]
33. Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections. Carson C; Naber KG Drugs; 2004; 64(12):1359-73. PubMed ID: 15200349 [TBL] [Abstract][Full Text] [Related]
34. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli. Chang UI; Kim HW; Wie SH Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868 [TBL] [Abstract][Full Text] [Related]
35. Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina. Uzunovic-Kamberovic S J Antimicrob Chemother; 2006 Aug; 58(2):344-8. PubMed ID: 16775214 [TBL] [Abstract][Full Text] [Related]
36. Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study. Aypak C; Altunsoy A; Düzgün N Ann Clin Microbiol Antimicrob; 2009 Oct; 8():27. PubMed ID: 19852849 [TBL] [Abstract][Full Text] [Related]
37. [Susceptibility of Escherichia coli strains isolated from persons with urinary tract infections in 2007 - 2008 to antimicrobial agents]. Kot B; Wicha J; Zak-Puławska Z Przegl Epidemiol; 2010; 64(2):307-12. PubMed ID: 20731243 [TBL] [Abstract][Full Text] [Related]
38. Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UK. Cottell JL; Webber MA J Med Microbiol; 2019 Feb; 68(2):161-168. PubMed ID: 30543320 [TBL] [Abstract][Full Text] [Related]
39. Community-acquired urinary tract infections in children: pathogens, antibiotic susceptibility and seasonal changes. Yolbaş I; Tekin R; Kelekci S; Tekin A; Okur MH; Ece A; Gunes A; Sen V Eur Rev Med Pharmacol Sci; 2013 Apr; 17(7):971-6. PubMed ID: 23640446 [TBL] [Abstract][Full Text] [Related]
40. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009. Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]